Intuitive Surgical (ISRG) Reports 510(k) Clearance for da Vinci Xi EndoWrist Stapler 30 Instruments, Reloads
- Wall St opens higher as some chip stocks bounce back after selloff
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- European stocks edge higher as dollar eases, oil prices fall
- Dollar rally stalls after rare FX warning from finance chiefs
- Oil extends losses on easing Middle East tension, demand concerns
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Crude Inventory Rose 2.7 Million Barrels Last Week, Says EIA
- Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
- Tesla, Blackstone, Las Vegas Sands fall premarket; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
Intuitive Surgical Announces U.S. Clearance for da Vinci Xi EndoWrist Stapler 30 Instruments and Reloads
March 14, 2016 8:30 AM EDTSUNNYVALE, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq: ISRG), the global leader in robotic-assisted minimally invasive surgery, today announced that the United States Food and Drug Administration has provided 510(k) clearance for the companys da Vinci® Xi EndoWrist Stapler 30 (30mm) instruments and reloads.
Availability of the Stapler 30 for the da Vinci Xi Surgical System expands the companys EndoWrist Stapler portfolio through the offering of new curved and straight tip instruments and four reloads. With General Surgery, Thoracic, Gynecologic and Urologic surgery indications, the Stapler 30 Curved-Tip instrument... More